Molecular analysis of the gene for the human vitamin-D-binding protein (group-specific component): allelic differences of the common genetic GC types - PubMed (original) (raw)

Molecular analysis of the gene for the human vitamin-D-binding protein (group-specific component): allelic differences of the common genetic GC types

A Braun et al. Hum Genet. 1992 Jun.

Abstract

DNA sequence analysis of the polymerase chain reaction products, including the coding region for amino acids 416 and 420, of the vitamin-D-binding protein (DBP, group-specific component, GC) shows allele-specific differences. The GC2 and GC1F phenotypes have an aspartic acid residue at amino acid position 416, whereas the GC1S phenotype has a glutamic acid at this position. In the GC2 phenotype, amino acid 420 is a lysine residue, and in the both common GC1 phenotypes, it is a threonine residue. The nucleotide exchanges involve a HaeIII (position 416) and a StyI (position 420) restriction site: the HaeIII restriction site is specific for the GC*1S allele and the StyI restriction site is specific for the GC*2 allele. We have tested 140 individual genomic DNA samples for the HaeIII site and 148 samples for the StyI site by restriction fragment length polymorphism (RFLP) analysis with a DBP-specific direct genomic DNA probe, and have compared these findings with the GC phenotype classification, by isoelectric focusing (IEF) of the corresponding plasma. The results of the HaeIII RFLP analysis and the IEF typing were in complete agreement. By using our DNA probe, we could disclose, in addition to the StyI site at amino acid position 420, two further StyI site downstream: one was specific for the GC*1S allele and another for the GC*1F allele. In 147 samples, there was agreement between the IEF GC typing and the analysis of the StyI restriction sites. In a single case, the observed result of the StyI-digest differed from the result expected after IEF classification: homozygous GC 1F-1F by IEF and heterozygous by StyI RFLP analysis. We discuss this finding as a recombination event or a possible silent allele in IEF typing. The GC polymorphism revealed by Southern blot analysis of StyI-digests provides an informative DNA marker system for chromosome 4q11-q13.

PubMed Disclaimer

Similar articles

• Molecular analysis of the human vitamin D binding protein (group specific component, Gc) in tuberous sclerosis complex (TSC).
  Rodriguez JA, Evans RL, Daiger SP, Northrup H. Rodriguez JA, et al. J Med Genet. 1997 Jun;34(6):509-11. doi: 10.1136/jmg.34.6.509. J Med Genet. 1997. PMID: 9192275 Free PMC article.
• The HLA-DQB alleles and amino acid variants of the vitamin D-binding protein in diabetic patients in Alsace.
  Ongagna JC, Kaltenbacher MC, Sapin R, Pinget M, Belcourt A. Ongagna JC, et al. Clin Biochem. 2001 Feb;34(1):59-63. doi: 10.1016/s0009-9120(00)00197-1. Clin Biochem. 2001. PMID: 11239517
• Molecular evaluation of an Alu repeat including a polymorphic variable poly(dA) (AluVpA) in the vitamin D binding protein (DBP) gene.
  Braun A, Bichlmaier R, Müller B, Cleve H. Braun A, et al. Hum Genet. 1993 Jan;90(5):526-32. doi: 10.1007/BF00217453. Hum Genet. 1993. PMID: 8381387
• Ethnic variation in vitamin D-binding protein (GC): a review of isoelectric focusing studies in human populations.
  Kamboh MI, Ferrell RE. Kamboh MI, et al. Hum Genet. 1986 Apr;72(4):281-93. doi: 10.1007/BF00290950. Hum Genet. 1986. PMID: 3516862 Review.
• Genetic analysis of nuclear DNA restriction fragment patterns.
  Gillet EM. Gillet EM. Genome. 1991 Oct;34(5):693-703. doi: 10.1139/g91-107. Genome. 1991. PMID: 1683328 Review.

Cited by

• Neural tube defects: from a proteomic standpoint.
  Puvirajesinghe TM, Borg JP. Puvirajesinghe TM, et al. Metabolites. 2015 Mar 17;5(1):164-83. doi: 10.3390/metabo5010164. Metabolites. 2015. PMID: 25789708 Free PMC article. Review.
• GC1f Vitamin D Binding Protein Isoform as a Marker of Severity in Autism Spectrum Disorders.
  Bolognesi E, Guerini FR, Sotgiu S, Chiappedi M, Carta A, Mensi MM, Agliardi C, Zanzottera M, Clerici M. Bolognesi E, et al. Nutrients. 2022 Dec 3;14(23):5153. doi: 10.3390/nu14235153. Nutrients. 2022. PMID: 36501185 Free PMC article.
• Vitamin D binding protein genotype and osteoporosis.
  Fang Y, van Meurs JB, Arp P, van Leeuwen JP, Hofman A, Pols HA, Uitterlinden AG. Fang Y, et al. Calcif Tissue Int. 2009 Aug;85(2):85-93. doi: 10.1007/s00223-009-9251-9. Epub 2009 Jun 2. Calcif Tissue Int. 2009. PMID: 19488670 Free PMC article.
• Mutations in the gene for X-linked adrenoleukodystrophy in patients with different clinical phenotypes.
  Braun A, Ambach H, Kammerer S, Rolinski B, Stöckler S, Rabl W, Gärtner J, Zierz S, Roscher AA. Braun A, et al. Am J Hum Genet. 1995 Apr;56(4):854-61. Am J Hum Genet. 1995. PMID: 7717396 Free PMC article.
• Effects of vitamin D binding protein phenotypes and vitamin D supplementation on serum total 25(OH)D and directly measured free 25(OH)D.
  Sollid ST, Hutchinson MY, Berg V, Fuskevåg OM, Figenschau Y, Thorsby PM, Jorde R. Sollid ST, et al. Eur J Endocrinol. 2016 Apr;174(4):445-52. doi: 10.1530/EJE-15-1089. Epub 2016 Jan 5. Eur J Endocrinol. 2016. PMID: 26733479 Free PMC article. Clinical Trial.

References

1. 1. Biochim Biophys Acta. 1986 Jun 5;871(2):189-98 - PubMed
2. 1. Ann N Y Acad Sci. 1988;538:60-8 - PubMed
3. 1. Hum Genet. 1979 Mar 12;47(2):193-8 - PubMed
4. 1. Vox Sang. 1988;54(4):215-25 - PubMed
5. 1. J Biol Chem. 1985 Feb 10;260(3):1804-10 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Other Literature Sources

  • The Lens - Patent Citations Database

• Molecular Biology Databases

  • GlyGen glycoinformatics resource

• Miscellaneous

  • NCI CPTAC Assay Portal